Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Feldman

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Circulation|April 25, 2001
Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST)A Deswal, N J Petersen, A M Feldman, et al.
British Journal of Clinical Pharmacology|March 22, 2001
The pharmacokinetics of etanercept in patients with heart failureO Soran, A M Feldman, V M Schneider, et al.
Journal of the American College of Cardiology|August 10, 2000
Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studiesS E Reis, R Holubkov, J B Young, et al.
Circulation|April 1, 1998
Heterogeneous immediate effects of partial left ventriculectomy on cardiac performanceJ Gorcsan, A M Feldman, R L Kormos, et al.
Clinical Pharmacology and Therapeutics|September 19, 2014
Response to "clarification of enrolled subjects in tolvaptan HF trials"A M Feldman, E Hamad, E Tsai, et al.
The American Journal of Cardiology|September 15, 1996
Dose dependence of chronic positive inotropic effect of vesnarinone in patients with congestive heart failure due to idiopathic or ischemic cardiomyopathyD A Kass, E Van Anden, L C Becker, et al.
Clinical Pharmacology and Therapeutics|December 19, 2013
Vasopressin antagonists for patients with acute heart failure: interpreting new clinical and translational dataA M Feldman, E Hamad, E J Tsai, et al.
Journal of Cardiovascular Pharmacology|April 1, 1991
Mr 40,000 and Mr 39,000 pertussis toxin substrates are increased in surgically denervated dog ventricular myocardiumR E Hershberger, A M Feldman, F L Anderson, et al.
Circulation|May 1, 1994
Ventricular systolic assessment in patients with dilated cardiomyopathy by preload-adjusted maximal power. Validation and noninvasive applicationT Sharir, M D Feldman, H Haber, et al.
Journal of the American College of Cardiology|September 1, 1997
Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomesS E Reis, R Holubkov, D Edmundowicz, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Circulation|April 25, 2001
Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST)A Deswal, N J Petersen, A M Feldman, et al.
British Journal of Clinical Pharmacology|March 22, 2001
The pharmacokinetics of etanercept in patients with heart failureO Soran, A M Feldman, V M Schneider, et al.
Journal of the American College of Cardiology|August 10, 2000
Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studiesS E Reis, R Holubkov, J B Young, et al.
Circulation|April 1, 1998
Heterogeneous immediate effects of partial left ventriculectomy on cardiac performanceJ Gorcsan, A M Feldman, R L Kormos, et al.
Clinical Pharmacology and Therapeutics|September 19, 2014
Response to "clarification of enrolled subjects in tolvaptan HF trials"A M Feldman, E Hamad, E Tsai, et al.
The American Journal of Cardiology|September 15, 1996
Dose dependence of chronic positive inotropic effect of vesnarinone in patients with congestive heart failure due to idiopathic or ischemic cardiomyopathyD A Kass, E Van Anden, L C Becker, et al.
Clinical Pharmacology and Therapeutics|December 19, 2013
Vasopressin antagonists for patients with acute heart failure: interpreting new clinical and translational dataA M Feldman, E Hamad, E J Tsai, et al.
Journal of Cardiovascular Pharmacology|April 1, 1991
Mr 40,000 and Mr 39,000 pertussis toxin substrates are increased in surgically denervated dog ventricular myocardiumR E Hershberger, A M Feldman, F L Anderson, et al.
Circulation|May 1, 1994
Ventricular systolic assessment in patients with dilated cardiomyopathy by preload-adjusted maximal power. Validation and noninvasive applicationT Sharir, M D Feldman, H Haber, et al.
Journal of the American College of Cardiology|September 1, 1997
Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomesS E Reis, R Holubkov, D Edmundowicz, et al.
Pageof 15